Whistleblower Program

About Gastroenterology

Glossary

2008 Quarterly Results

1st Quarter - Axcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of $92.9 Million in the First Quarter

MD&A (PDF 0.411 MB) and
Financial statements (PDF 0.373 MB)


2007 Quarterly Results    


2006 Quarterly Results    


2005 Quarterly Results    


2004 Quarterly Results    


 


Download Adobe® Reader